GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi

What GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi does

GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi is a private, founder-owned IVF and reproductive biotechnology center headquartered in Çankaya, Ankara, operating under the legal entity Gensa Genel Sağlık Hizmetleri San. ve Tic. A.Ş. and trading under brand variants including Gen-Art IVF Center and Gen-Art Women's Health and IVF Center. Founded in 2002 by Prof. Dr. Volkan Baltacı, the center offers core reproductive services — IVF/ICSI, IUI, hysteroscopy, egg and embryo cryopreservation, TESE/micro-TESE — and supplements them with a broad advanced-technologies menu: PGT-A/M/SR using NGS, WES-based male infertility panels, spermatogenesis gene expression analysis, flow cytometry for sperm DNA damage and ROS, piezoelectric activation for fertilization failure, non-invasive PGT (NIPGT), macrophage vaccine, PRP ovarian/endometrial therapy, and microchip sperm selection. Disclosed outcomes include 95-99% embryo survival after thawing, ~0.3% embryo damage during PGT biopsy, PGT coverage of 150+ single-gene diseases, and recognition as having performed the first PGT for SMA in Turkey (2007).

The business operates on a direct-to-consumer, fee-for-service healthcare model with quote-based, individually priced cycles rather than published pricing. Revenue is generated per treatment (IVF/ICSI, PGT, cryopreservation storage, surgical sperm retrieval, IUI, hysteroscopy) plus a dedicated health tourism line targeting international patients via WhatsApp pre-consultation, remote ovulation management, and on-site treatment with multilingual interpretation; a wholly-owned Baku, Azerbaijan branch opened in 2023 supports Caucasus and Central Asia patient flows. Patient mix centers on couples with infertility, couples at genetic risk, male-factor (including azoospermia) cases, and recurring-IVF-failure cases referred to a weekly multi-disciplinary Clinical Council that produces written treatment roadmaps. The center's go-to-market relies on bilingual website content (Turkish/English), a medical blog, and the WhatsApp channel, with no evidence of enterprise or B2B contracts; founder Prof. Dr. Volkan Baltacı brings over three decades of reproductive genetics experience and 48+ peer-reviewed publications, supported by embryologists, OB/GYNs, nurses, and patient counselors across both locations.

Name

GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi

Legal name

Gensa Genel Sağlık Hizmetleri San. ve Tic. A.Ş

Website

https://genart.com.tr

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

GenArt is a founder-owned Ankara-based IVF and reproductive biotechnology center offering IVF/ICSI, PGT, cryopreservation, and advanced procedures, serving couples with infertility and genetic risk and health-tourism patients at its Turkey and Azerbaijan locations.

Ownership category

akta.pro rank

Product category

Assisted Reproductive Technology / Fertility Healthcare Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

akta.pro industry

PRIMARYHLAFAJAD

Fertility, Reproductive Endocrinology & IVF Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAKAJAC

Reproductive Endocrinology & Infertility (IVF/Fertility)

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAAALAJ

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAAALAD

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAKAOAD

Male Reproductive & Sexual Medicine (Andrology)

Healthcare & Life Sciences/Specialist Medical Practice/Urology

Keywords

• IVF treatments
• Reproductive genetics
• Fertility services
• Preimplantation genetic testing
• Reproductive biotechnology

Headquarters

HQ city

Ankara

HQ country

Türkiye

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVF/IVF Treatment Services: In vitro fertilization treatment including egg collection, fertilization, embryo culture, and embryo transfer procedures. Services include conventional IVF and ICSI.
2. Genetic Testing Services: Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), carrier screening, prenatal genetic testing, and other diagnostic genetic tests performed on embryos, couples, and families.
3. Cryopreservation Services: Egg freezing, embryo freezing and storage services using vitrification method.
4. TESE Procedures: Surgical sperm extraction procedures for azoospermia patients, including micro-TESE.
5. Health Tourism Services: International patient services including consultation, treatment planning, and coordination for couples traveling from abroad.
6. IUI (Intrauterine Insemination): Less invasive fertility treatment involving sperm washing and direct placement into uterus.
7. Hysteroscopy Services: Minimally invasive surgical procedures for viewing and treating the inside of the uterus.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

GenArt is a fertility clinic group that performs in vitro fertilization (IVF/ICSI) and related assisted reproduction procedures, complemented by an in-house reproductive genetics laboratory offering preimplantation genetic testing (PGT-A, PGT-SR, PGT-M). The center also provides male-factor fertility surgery such as micro-TESE, oocyte/embryo/sperm cryopreservation, and reproductive immunology workups for couples facing recurrent IVF failure.

Product overview

GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi is an IVF and reproductive biotechnology center offering a comprehensive portfolio of assisted reproductive technologies. The core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Hysteroscopy, Egg Freezing, Embryo Cryopreservation, TESE Procedures, and Health Tourism services. The center distinguishes itself through advanced genetic and technological applications including Preimplantation Genetic Testing (PGT) with three variants (PGT-A, PGT-M, PGT-SR), Macrophage Vaccine, Piezoelectric Activation, Flow Cytometry Tests, PRP Method, Microchip sperm selection, Next Generation Tests in Male Infertility, and comprehensive Genetics services. The center also offers a Clinical Council for recurrent IVF failure cases that brings together specialists from multiple disciplines. Founded in 2002 in Ankara, the center has achieved notable milestones including the first PGT application for SMA disease in 2007 and expansion with a Baku branch in 2023.

Differentiator

Problem solved

Functional benefit

Products and services

• IVF / ICSI Treatment In vitro fertilization with or without intracytoplasmic sperm injection (ICSI), covering ovarian stimulation, oocyte retrieval, fertilization, and embryo transfer for couples with infertility.
• Preimplantation Genetic Testing (PGT-A, PGT-SR, PGT-M) Embryo genetic analysis for aneuploidy (PGT-A), structural rearrangements (PGT-SR), and monogenic/single-gene disorders (PGT-M) using trophectoderm biopsy and NGS readout.
• Micro-TESE (Microsurgical Testicular Sperm Extraction) Microsurgical retrieval of sperm directly from testicular tissue for men with obstructive or non-obstructive azoospermia, intended for use with IVF/ICSI.
• Oocyte, Embryo, and Sperm Cryopreservation (Vitrification) Vitrification-based freezing and long-term storage of oocytes, embryos, and sperm for elective fertility preservation or surplus embryo storage.
• Reproductive Immunology Workup and Treatment Diagnostic and therapeutic protocols for couples with recurrent IVF failure, recurrent miscarriage, or suspected immune-mediated implantation issues.
• Embryology Laboratory Services (Blastocyst Culture and Embryo Biopsy) Extended embryo culture to blastocyst stage and trophectoderm biopsy to support PGT, performed in the clinic's embryology lab.

Quantifiable outcome

• Tens of thousands of healthy babies delivered through genetic selection over 20+ years
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Jinemed Hospital: Istanbul-based women's health and IVF hospital offering IVF, PGT and reproductive genetics with a strong medical-tourism focus. Comparable Turkish peer competing for the same international patient pool.
• Centrum Clinic (Centrum Tüp Bebek): Turkish IVF clinic with PGT, micro-TESE, and advanced embryology services. Directly comparable mid-sized Turkish IVF competitor with similar technology breadth.
• Igenomix: Specialized reproductive genetics and PGT laboratory serving IVF clinics worldwide. Highly comparable to GenArt's PGT-M, PGT-SR and PGT-A capabilities and competes for the same genetic-testing referrals.
• Genea Biomedx: Australia-origin IVF clinic network and embryology technology provider with strong PGT and advanced embryology focus. Comparable in clinical sophistication and genetics-integrated IVF model.
• Bahçeci Sağlık Grubu: One of Turkey's largest IVF-focused clinic chains offering IVF, PGT, andrology and genetic services. Directly competes with GenArt in the Turkish IVF market and on PGT capabilities.

Broad incumbents

• Memorial Healthcare Group: Major Turkish private hospital group with IVF centers across multiple cities. Comparable in Turkey-based service delivery and medical-tourism positioning, but offers IVF as part of a broader multi-specialty portfolio.
• IVI-RMA Global: Global IVF and reproductive medicine group operating across Europe, Americas, and Asia with full PGT and genetic services. A scaled incumbent against which GenArt competes for international medical-tourism patients.
• Virtus Health: ASX-listed global IVF and fertility services group with clinics across multiple geographies. A scaled incumbent comparable in service breadth, though broader and less genetics-specialized than GenArt.

Others

• CooperSurgical: Global provider of IVF consumables, devices, and genetic-testing services (including PGT via its subsidiaries). Not a direct clinic competitor but an adjacent ecosystem player whose technology stack GenArt utilizes.

Emerging players

• Natera: US-listed genetic diagnostics company offering PGT and reproductive health testing panels (Spectrum, Empower). Overlaps directly with GenArt's PGT and carrier-screening services for cross-border patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/genarttupbebek

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenArt Tüp Bebek, Kadın Sağlığı ve Üreme Biyoteknoloji Merkezi